Skip to content

Ocera Therapeutics, Inc.

CIK 0001274644

← back to feed
Revenue (TTM)
$609K
+357.9% YoY Q3 Oct 2017
Net Income (TTM)
−$26.21M
+27.7% YoY Q3 Oct 2017
EPS Diluted (TTM)
—
Q3 Oct 2017
Gross Margin
—
Q3 Oct 2017
Operating Margin
-2,371.9%
Q3 Oct 2017
Net Margin
-4,303.8%
Q3 Oct 2017
Free Cash Flow (TTM)
−$22.03M
Q3 Oct 2017
Cash
$14.35M
Q3 Oct 2017
Total Debt
—
Q3 Oct 2017
Shares Outstanding
26.51M sh
Q3 Oct 2017

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings